Dimension Therapeutics, Inc. Stock-Based Compensation
Dimension Therapeutics, Inc. reported Stock-Based Compensation of $2.92 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2017-11-06
- Dimension Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-09-30 was $985.00K, a 6.99% decline year-over-year.
- Dimension Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2016-09-30 was $1.06M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month |
|---|---|---|---|
| 2017-09-30 | $985.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $2.92M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $1.93M 10-Q · filed 2017-08-08 | ||
| 2016-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $2.39M 10-Q · filed 2017-11-06 | |
| 2016-06-30 | $1.33M 10-Q · filed 2017-08-08 |